Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report

The use of sacubitril/valsartan significantly reduces death or hospitalization in patients with ejection fraction < 40%. There is no study evaluating this drug effects in non‐compaction cardiomyopathy (NCCM) individuals. The aim of this article is to report a case of a patient with NCCM initially...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonatto, Marcely Gimenes, Albanez, Rodrigo, Salemi, Vera Maria Cury, Moura, Lídia Zytynski
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261575/
https://www.ncbi.nlm.nih.gov/pubmed/32304161
http://dx.doi.org/10.1002/ehf2.12713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261575/
https://www.ncbi.nlm.nih.gov/pubmed/32304161
http://dx.doi.org/10.1002/ehf2.12713

Ejemplares similares